Humana Ab Stock Target Price
| HUM Stock | SEK 31.55 0.05 0.16% |
Humana AB fundamentals help investors to digest information that contributes to Humana AB's financial success or failures. It also enables traders to predict the movement of Humana Stock. The fundamental analysis module provides a way to measure Humana AB's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Humana AB stock.
Humana |
Humana Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Humana AB's direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Humana AB could also be used in its relative valuation, which is a method of valuing Humana AB by comparing valuation metrics of similar companies.Humana AB is currently under evaluation in target price category among related companies.
Humana Fundamentals
| Return On Equity | 0.0794 | |||
| Return On Asset | 0.0292 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 6.55 B | |||
| Shares Outstanding | 47.83 M | |||
| Shares Owned By Insiders | 9.16 % | |||
| Shares Owned By Institutions | 71.58 % | |||
| Price To Earning | 13.39 X | |||
| Price To Book | 0.71 X | |||
| Price To Sales | 0.22 X | |||
| Revenue | 8.19 B | |||
| Gross Profit | 1.99 B | |||
| EBITDA | 912 M | |||
| Net Income | 354 M | |||
| Cash And Equivalents | 695 M | |||
| Cash Per Share | 9.20 X | |||
| Total Debt | 4.7 B | |||
| Debt To Equity | 200.80 % | |||
| Current Ratio | 0.79 X | |||
| Book Value Per Share | 57.27 X | |||
| Cash Flow From Operations | 689 M | |||
| Earnings Per Share | 6.27 X | |||
| Target Price | 36.17 | |||
| Number Of Employees | 12.43 K | |||
| Beta | 0.63 | |||
| Market Capitalization | 735.56 M | |||
| Total Asset | 9 B | |||
| Retained Earnings | 440 M | |||
| Working Capital | 151 M | |||
| Current Asset | 1.21 B | |||
| Current Liabilities | 1.06 B | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 9 B |
About Humana AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Humana AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Humana AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Humana AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Humana AB
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Humana AB position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Humana AB will appreciate offsetting losses from the drop in the long position's value.Moving together with Humana Stock
| 0.81 | KAR | Karnov Group AB | PairCorr |
| 0.9 | AZN | AstraZeneca PLC | PairCorr |
Moving against Humana Stock
| 0.87 | EVO | Evolution AB | PairCorr |
| 0.6 | ALM | ALM Equity AB | PairCorr |
The ability to find closely correlated positions to Humana AB could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Humana AB when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Humana AB - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Humana AB to buy it.
The correlation of Humana AB is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Humana AB moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Humana AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Humana AB can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Humana AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for Humana Stock analysis
When running Humana AB's price analysis, check to measure Humana AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humana AB is operating at the current time. Most of Humana AB's value examination focuses on studying past and present price action to predict the probability of Humana AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humana AB's price. Additionally, you may evaluate how the addition of Humana AB to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |